Lifestyle and nutritional imbalances associated with Western diseases: Causes and consequences of chronic systemic low-grade inflammation in an evolutionary context

Journal of Nutritional Biochemistry

Volumn 24, Issue 7, 2013, Pages 1183-1201

  Ruiz Núñez, Begoña ^a   Pruimboom, Leo ^b   Dijck Brouwer, D A Janneke ^a   Muskiet, Frits A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anti inflammatory nutrients; Antioxidant network; Antioxidants; Brain; Cholesterol; Chronic systemic low grade inflammation; Diet; Encephalization quotient; Evolution; Fatty acids; Fish oil; Fruits; Glucose; Homeostasis; Immune system; Insulin resistance; Lifestyle; Metabolic syndrome; Pro inflammatory nutrients; Resoleomics; Vegetables

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; GLUCOSE;

ANTIINFLAMMATORY ACTIVITY; BRAIN GROWTH; CHOLESTEROL TRANSPORT; CHRONIC INFLAMMATION; CHRONIC STRESS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EATING HABIT; ENVIRONMENTAL FACTOR; EVOLUTIONARY ADAPTATION; FAT INTAKE; GLUCOSE UTILIZATION; HEREDITY; HUMAN; IMMUNOMODULATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MICROFLORA; NONHUMAN; NUTRIENT SUPPLY; NUTRITIONAL DISORDER; OXIDATIVE STRESS; PALEOLITHIC; PATHOGENESIS; PHYSICAL ACTIVITY; POLLUTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DEPRIVATION; BRAIN; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; LIFESTYLE; METABOLISM; NUTRITIONAL STATUS;

BRAIN; GLUCOSE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIFE STYLE; NUTRITIONAL STATUS;

EID: 84879308759     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.02.009     Document Type: Review

References (334)

1. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005, 25:391-406.
2. Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365(9467):1333-1346.
3. Straub R.H. Concepts of evolutionary medicine and energy regulation contribute to the etiology of systemic chronic inflammatory diseases. Brain Behav Immun 2011, 25(1):1-5.
4. Straub R.H., Cutolo M., Buttgereit F., Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 2010, 267(6):543-560.
5. Murch O., Collin M., Hinds C.J., Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 2007, 33(1):13-24.
6. Wendel M., Paul R., Heller A.R. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med 2007, 33(1):25-35.
7. Van Leeuwen H.J., Heezius E.C.J.M., Dallinga G.M., van Strijp J.A.G., Verhoef J., van Kessel K.P.M. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003, 31(5):1359-1366.
8. van Leeuwen H.J., van Beek A.P., Dallinga-Thie G.M., van Strijp J.A., Verhoef J., van Kessel K.P. The role of high density lipoprotein in sepsis. Neth J Med 2001, 59(3):102-110.
9. Van Amersfoort E.S., Van Berkel T.J.C., Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003, 16(3):379-414.
10. Hudgins L.C., Parker T.S., Levine D.M., Gordon B.R., Saal S.D., Jiang X., et al. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 2003, 44(8):1489-1498.
11. Leonard W.R., Robertson M.L., Snodgrass J.J., Kuzawa C.W. Metabolic correlates of hominid brain evolution. Comp Biochem Physiol A Mol Integr Physiol 2003, 136(1):5-15.
12. Broadhurst C.L., Cunnane S.C., Crawford M.A. Rift valley lake fish and shellfish provided brain-specific nutrition for early Homo. Br J Nutr 1998, 79(1):3-21.
13. Broadhurst C.L., Wang Y., Crawford M.A., Cunnane S.C., Parkington J.E., Schmidt W.F. Brain-specific lipids from marine, lacustrine, or terrestrial food resources: Potential impact on early African Homo sapiens. Comp Biochem Physiol B Biochem Mol Biol 2002, 131(4):653-673.
14. Gibbons A. Becoming human. In search of the first hominids. Science 2002, 295(5558):1214-1219.
15. Muskiet F.A.J., Kuipers R.S. Lessons from shore-based hunter-gatherer diets in East Africa. Human Brain Evolution: The Influence of Freshwater and Marine Food Resources 2010, 77-104. John Wiley & Sons, Inc., Hoboken, NJ. S.C. Cunnane, K.M. Stewart (Eds.).
16. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., et al. Origins and evolution of the Western diet: Health implications for the 21st century. Am J Clin Nutr 2005, 81(2):341-354.
17. Muskiet F.A.J. Evolutionaire geneeskunde. U bent wat u eet, maar u moet weer worden wat u at. Ned Tijdschr Klin Chem Labgeneesk 2005, 163-184.
18. Brown P., Sutikna T., Morwood M.J., Soejono R.P., Jatmiko, Saptomo E.W., et al. A new small-bodied hominin from the late pleistocene of Flores, Indonesia. Nature 2004, 431(7012):1055-1061.
19. Aiello L.C., Wheeler P. The expensive-tissue hypothesis: the brain and the digestive system in human and primate evolution. Curr Anthropol 1995, 36(2):199-221.
20. Leonard W.R., Snodgrass J.J., Robertson M.L. Effects of brain evolution on human nutrition and metabolism. Annu Rev Nutr 2007, 27:311-327.
21. Cunnane S.C., Crawford M.A. Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp Biochem Physiol A Mol Integr Physiol 2003, 136(1):17-26.
22. Kaindl A.M., Passemard S., Kumar P., Kraemer N., Issa L., Zwirner A., et al. Many roads lead to primary autosomal recessive microcephaly. Prog Neurobiol 2010, 90(3):363-383.
23. Williams C.A., Dagli A., Battaglia A. Genetic disorders associated with macrocephaly. Am J Med Genet A 2008, 146A(15):2023-2037.
24. Abzhanov A., Kuo W.P., Hartmann C., Grant B.R., Grant P.R., Tabin C.J. The calmodulin pathway and evolution of elongated beak morphology in Darwin's finches. Nature 2006, 442(7102):563-567.
25. Patel N.H. Evolutionary biology: How to build a longer beak. Nature 2006, 442(7102):515-516.
26. Fontana L., Klein S., Holloszy J.O. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr) 2010, 32(1):97-9108.
27. Peters A. The selfish brain: competition for energy resources. Am J Hum Biol 2011, 23(1):29-34.
28. Yajnik C.S. Obesity epidemic in India: intrauterine origins?. Proc Nutr Soc 2004, 63(3):387-396.
29. Azevedo F.A.C., Carvalho L.R.B., Grinberg L.T., Farfel J.M., Ferretti R.E.L., Leite R.E.P., et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 2009, 513(5):532-541.
30. Herculano-Houzel S. Coordinated scaling of cortical and cerebellar numbers of neurons. Front Neuroanat. 2010, 4:12.
31. Gabi M., Collins C.E., Wong P., Torres L.B., Kaas J.H., Herculano-Houzel S. Cellular scaling rules for the brains of an extended number of primate species. Brain Behav Evol 2010, 76(1):32-44.
32. Herculano-Houzel S. Scaling of brain metabolism with a fixed energy budget per neuron: Implications for neuronal activity, plasticity and evolution. PLoS One 2011, 6(3):e17514.
33. Deaner R.O., Isler K., Burkart J., van Schaik C. Overall brain size, and not encephalization quotient, best predicts cognitive ability across non-human primates. Brain Behav Evol 2007, 70(2):115-124.
34. Roth G., Dicke U. Evolution of the brain and intelligence. Trends Cogn Sci (Regul Ed) 2005, 9(5):250-257.
35. Dinuzzo M., Mangia S., Maraviglia B., Giove F. The role of astrocytic glycogen in supporting the energetics of neuronal activity. Neurochem Res 2012, 37:2432-2438.
36. Colagiuri S., Brand Miller J. The 'carnivore connection'. Evolutionary aspects of insulin resistance. Eur J Clin Nutr 2002, 56(Suppl 1):S30-S35.
37. Cahill G.F. Fuel metabolism in starvation. Annu Rev Nutr 2006, 26:1-22.
38. Hadden D.R., McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 2009, 14(2):66-71.
39. Calder P.C., Dimitriadis G., Newsholme P. Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr Opin Clin Nutr Metab Care 2007, 10(4):531-540.
40. Gluckman P.D., Hanson M.A. The consequences of being born small. An adaptive perspective. Horm Res 2006, 65(Suppl 3):5-14.
41. Gluckman P., Hanson M., Morton S.M.B., Pinal C. Life-long echoes. A critical analysis of the developmental origins of adult disease model. Biol Neonate 2005, 87(2):127-139.
42. Fall C.H.D. The fetal and early life origins of adult disease. Indian Pediatr 2003, 40(5):480-502.
43. Lumbers E.R., Yu Z.Y., Gibson K.J. The selfish brain and the Barker hypothesis. Clin Exp Pharmacol Physiol 2001, 28(11):942-947.
44. Koffler M., Kisch E.S. Starvation diet and very-low-calorie diets may induce insulin resistance and overt diabetes mellitus. J Diabetes Complications 1996, 10(2):109-112.
45. Kirwan J.P., Hauguel-De Mouzon S., Lepercq J., Challier J., Huston-Presley L., Friedman J.E., et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51(7):2207-2213.
46. Lain K.Y., Catalano P.M. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007, 50(4):938-948.
47. Hauguel-de Mouzon S., Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006, 27(8):794-798.
48. de Luca C., Olefsky J.M. Inflammation and insulin resistance. FEBS Lett 2008, 582(1):97-105.
49. Horng T., Hotamisligil G.S. Linking the inflammasome to obesity-related disease. Nat Med 2011, 17(2):164-165.
50. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
51. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008, 8(12):923-934.
52. Lee J.Y., Zhao L., Hwang D.H. Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 2010, 68(1):38-61.
53. Biddinger S.B., Kahn C.R. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 2006, 68:123-158.
54. Sarafidis P.A., Bakris G.L. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?. Am J Nephrol 2007, 27(1):44-54.
55. Warner M.H., Beckett G.J. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010, 205(1):1-13.
56. Kwakkel J., Fliers E., Boelen A. Illness-induced changes in thyroid hormone metabolism: focus on the tissue level. Neth J Med 2011, 69(5):224-228.
57. Dentice M., Salvatore D. Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. J Endocrinol 2011, 209(3):273-282.
58. Roos A., Bakker S.J., Links T.P., Gans R.O., Wolffenbuttel B.H. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007, 92(2):491-496.
59. Ruhla S., Weickert M.O., Arafat A.M., Osterhoff M., Isken F., Spranger J., et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 2010, 72(5):696-701.
60. Tuzcu A., Bahceci M., Gokalp D., Tuzun Y., Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J 2005, 52(1):89-94.
61. Surks M.I., Ocampo E. Subclinical thyroid disease. Am J Med 1996, 100(2):217-223.
62. Jones D.D., May K.E., Geraci S.A. Subclinical thyroid disease. Am J Med 2010, 123(6):502-504.
63. Ruhla S., Arafat A.M., Weickert M.O., Osterhoff M., Isken F., Spranger J., et al. T3/rT3-ratio is associated with insulin resistance independent of TSH. Horm Metab Res 2011, 43(2):130-134.
64. Boelen A., Wiersinga W.M., Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 2008, 18(2):123-129.
65. Esteve E., Ricart W., Fernandez-Real J.M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005, 24(1):16-31.
66. Khovidhunkit W., Kim M., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., et al. Thematic review series: The pathogenesis of atherosclerosis. effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J Lipid Res 2004, 45(7):1169-1196.
67. Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM 2003, 96(12):927-934.
68. Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 2000, 356(9233):930-933.
69. Kitchens R.L., Thompson P.A., Munford R.S., O'Keefe G.E. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003, 44(12):2339-2348.
70. Leigh S.E.A., Foster A.H., Whittall R.A., Hubbart C.S., Humphries S.E. Update and analysis of the University College London. Low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 2008, 72:485-498.
71. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review. Am J Epidemiol 2004, 160(5):407-420.
72. Sijbrands E.J., Westendorp R.G., Defesche J.C., de Meier P.H., Smelt A.H., Kastelein J.J. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: Family tree mortality study. BMJ 2001, 322(7293):1019-1023.
73. Netea M.G., Demacker P.N., Kullberg B.J., Boerman O.C., Verschueren I., Stalenhoef A.F., et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe Gram-negative infections. J Clin Invest 1996, 97(6):1366-1372.
74. Solano M.P., Goldberg R.B. Management of dyslipidemia in diabetes. Cardiol Rev 2006, 14(3):125-135.
75. Feingold K.R., Grunfeld C. The acute phase response inhibits reverse cholesterol transport. J Lipid Res 2010, 51(4):682-684.
76. Rogers J. The inflammatory response in Alzheimer's disease. J Periodontol 2008, 79(8):1535-1543.
77. Egger G., Dixon J. Non-nutrient causes of low-grade, systemic inflammation: support for a 'canary in the mineshaft' view of obesity in chronic disease. Obes Rev 2011, 12(5):339-345.
78. Galland L. Diet and inflammation. Nutr Clin Pract 2010, 25(6):634-640.
79. Anand P., Kunnumakkara A.B., Kunnumakara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008, 25(9):2097-2116.
80. Egger G., Dixon J. Inflammatory effects of nutritional stimuli: Further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev 2010, 11(2):137-149.
81. Egger G., Dixon J. Obesity and chronic disease: always offender or often just accomplice?. Br J Nutr 2009, 102(8):1238-1242.
82. Jimenez-Gomez Y., Lopez-Miranda J., Blanco-Colio L.M., Marin C., Perez-Martinez P., Ruano J., et al. Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis 2009, 204(2):e70-e76.
83. Mozaffarian D. Trans fatty acids. Effects on systemic inflammation and endothelial function. Atheroscler Suppl 2006, 7(2):29-32.
84. Mozaffarian D., Aro A., Willett W.C. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009, 63(Suppl. 2):5-21.
85. Serhan C.N., Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 2008, 153(Suppl. 1):200-215.
86. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233(6):674-688.
87. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6):1519.
88. He K., Liu K., Daviglus M.L., Jenny N.S., Mayer-Davis E., Jiang R., et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the multi-ethnic study of atherosclerosis [MESA]). Am J Cardiol 2009, 103(9):1238-1243.
89. Din J.N., Newby D.E., Flapan A.D. Omega 3 fatty acids and cardiovascular disease. Fishing for a natural treatment. BMJ 2004, 328(7430):30-35.
90. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008, 4(8):404-412.
91. Nagpal S., Na S., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005, 26(5):662-687.
92. Peterson C.A., Heffernan M.E. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond) 2008, 5:10.
93. Shea M.K., Booth S.L., Massaro J.M., Jacques P.F., D'Agostino R.B.S., Dawson-Hughes B., et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham offspring study. Am J Epidemiol 2008, 167(3):313-320.
94. Kim D.J., Xun P., Liu K., Loria C., Yokota K., Jacobs D.R., et al. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010, 33(12):2604-2610.
95. Laires M.J., Monteiro C.P., Bicho M. Role of cellular magnesium in health and human disease. Front Biosci 2004, 9:262-276.
96. Laires M.J., Monteiro C. Exercise, magnesium and immune function. Magnes Res 2008, 21(2):92-96.
97. Cani P.D., Delzenne N.M. Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: Focus on this neglected partner. Acta Gastroenterol Belg 2010, 73(2):267-269.
98. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15(13):1546-1558.
99. Liu S., Manson J.E., Buring J.E., Stampfer M.J., Willett W.C., Ridker P.M. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75(3):492-498.
100. Levitan E.B., Cook N.R., Stampfer M.J., Ridker P.M., Rexrode K.M., Buring J.E., et al. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metab Clin Exp 2008, 57(3):437-443.
101. Vertuani S., Angusti A., Manfredini S. The antioxidants and pro-antioxidants network: An overview. Curr Pharm Des 2004, 10(14):1677-1694.
102. Benzie I.F.F. Evolution of dietary antioxidants. Comp Biochem Physiol A Mol Integr Physiol 2003, 136(1):113-126.
103. Pan M., Lai C., Dushenkov S., Ho C. Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem 2009, 57(11):4467-4477.
104. Holt E.M., Steffen L.M., Moran A., Basu S., Steinberger J., Ross J.A., et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc 2009, 109(3):414-421.
105. Cavicchia P.P., Steck S.E., Hurley T.G., Hussey J.R., Ma Y., Ockene I.S., et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 2009, 139(12):2365-2372.
106. Koren O., Spor A., Felin J., Fak F., Stombaugh J., Tremaroli V., et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4592-4598.
107. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010, 107(33):14691-14696.
108. Humphrey L.L., Fu R., Buckley D.I., Freeman M., Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008, 23(12):2079-2086.
109. Takahashi N., Honda T., Domon H., Nakajima T., Tabeta K., Yamazaki K. Interleukin-1 receptor-associated kinase-M in gingival epithelial cells attenuates the inflammatory response elicited by porphyromonas gingivalis. J Periodontal Res 2010, 45(4):512-519.
110. Nakajima T., Yamazaki K. Periodontal disease and risk of atherosclerotic coronary heart disease. Odontology 2009, 97(2):84-91.
111. Garcia-Bueno B., Caso J.R., Leza J.C. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci Biobehav Rev 2008, 32(6):1136-1151.
112. Black P.H., Garbutt L.D. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002, 52(1):1-23.
113. Huffman K.M., Samsa G.P., Slentz C.A., Duscha B.D., Johnson J.L., Bales C.W., et al. Response of high-sensitivity C-reactive protein to exercise training in an at-risk population. Am Heart J 2006, 152(4):793-800.
114. Petersen A., Marie W., Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98(4):1154-1162.
115. Petersen A.M.W., Penkowa M., Iversen M., Frydelund-Larsen L., Andersen J.L., Mortensen J., et al. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung 2007, 185(3):161-171.
116. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutr Rev 2007, 65(12):208-212.
117. Roubenoff R. Molecular basis of inflammation: relationships between catabolic cytokines, hormones, energy balance, and muscle. JPEN J Parenter Enteral Nutr 2008, 32(6):630-632.
118. Handschin C., Spiegelman B.M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008, 454(7203):463-469.
119. Simpson N., Dinges D.F. Sleep and inflammation. Nutr Rev 2007, 65(12):244-252.
120. Meier-Ewert H.K., Ridker P.M., Rifai N., Regan M.M., Price N.J., Dinges D.F., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004, 43(4):678-683.
121. Irwin M.R., Wang M., Ribeiro D., Cho H.J., Olmstead R., Breen E.C., et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry 2008, 64(6):538-540.
122. Irwin M.R., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006, 166(16):1756-1762.
123. Mullington J.M., Simpson N.S., Meier-Ewert H.K., Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab 2010, 24(5):775-784.
124. Forsythe C.E., Phinney S.D., Fernandez M.L., Quann E.E., Wood R.J., Bibus D.M., et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008, 43(1):65-77.
125. Forsythe C.E., Phinney S.D., Feinman R.D., Volk B.M., Freidenreich D., Quann E., et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 2010, 45(10):947-962.
126. Volek J.S., Fernandez M.L., Feinman R.D., Phinney S.D. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res 2008, 47(5):307-318.
127. Volek J.S., Ballard K.D., Silvestre R., Judelson D.A., Quann E.E., Forsythe C.E., et al. Effects of dietary carbohydrate restriction versus low-fat diet on flow-mediated dilation. Metab Clin Exp 2009, 58(12):1769-1777.
128. Volek J.S., Phinney S.D., Forsythe C.E., Quann E.E., Wood R.J., Puglisi M.J., et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 2009, 44(4):297-309.
129. Esposito K., Giugliano D. Mediterranean diet and the metabolic syndrome: the end of the beginning. Metab Syndr Relat Disord 2010, 8(3):197-200.
130. Giugliano D., Ceriello A., Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006, 48(4):677-685.
131. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296(15):1885-1899.
132. Eisenächer K., Krug A. Regulation of RLR-mediated innate immune signaling - It is all about keeping the balance. Eur J Cell Biol 2012, 91(1):36-47.
133. Serhan C.N., Chiang N. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: Entrée for resoleomics. Rheum Dis Clin North Am 2004, 30(1):69-95.
134. Serhan C.N. Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 2005, 105(1):7-21.
135. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008, 3:279-312.
136. Ariel A., Serhan C.N. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007, 28(4):176-183.
137. Chiang N., Fredman G., Backhed F., Oh S.F., Vickery T., Schmidt B.A., et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012, 484(7395):524-528.
138. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140(6):871-882.
139. National Institute for Public Health and the Environment, The Netherlands (RIVM) Our food, our heath. healthy diet and safe food in The Netherlands 2006, National Institute for Public Health and the Environment, Bilthoven, [Report No.: 270555009].
140. Hou J.K., Abraham B., El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011, 106(4):563-573.
141. O'Neil C.E., Keast D.R., Fulgoni V.L., Nicklas T.A. Tree nut consumption improves nutrient intake and diet quality in US adults: An analysis of National Health and nutrition examination survey (NHANES) 1999-2004. Asia Pac J Clin Nutr 2010, 19(1):142-150.
142. Guenther P.M., Dodd K.W., Reedy J., Krebs-Smith S.M. Most Americans eat much less than recommended amounts of fruits and vegetables. J Am Diet Assoc 2006, 106(9):1371-1379.
143. Marriott B.P., Olsho L., Hadden L., Connor P. Intake of added sugars and selected nutrients in the United States, National Health and nutrition examination survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr 2010, 50(3):228-258.
144. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJL, et al. The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. (4):e1000058.
145. Health Council of the Netherlands Dietary reference intakes: energy, proteins, fats and digestible carbohydrates. The Hague: Health council of The Netherlands. Publication no. 2001/19. 2001.
146. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757.
147. van Rossum C, Fransen HP, Verkaik-Kloosterman J, Buurma-Rethans E, Ocké MC. Dutch National food consumption survey 2007-2010. Diet of children and adults aged 7 to 69 years. 10-5-2011. Report No.: RIVM Report 350050006.
148. The NOAA administration per capita consumption [Internet] Available from:. http://www.st.nmfs.noaa.gov/st1/fus/fus04/08_perita2004.pdf.
149. Per capita consumption [Internet] Available from:. http://www.st.nmfs.noaa.gov/st1/fus/fus04/08_perita2004.pdf.
150. He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R., et al. Accumulated evidence on fish consumption and coronary heart disease mortality. Circulation 2004, 109(22):2705-2711.
151. de Goede J., Geleijnse J.M., Boer J.M.A., Kromhout D., Verschuren W.M.M. Marine (n-3) fatty acids, fish consumption, and the 10-year risk of fatal and nonfatal coronary heart disease in a large population of Dutch adults with low fish intake. J Nutr May 2010, 140(5):1023-1028.
152. U.S.Department of Agriculture and U.S.Department of Health and Human Services Dietary Guidelines for Americans, 2010 2010, U.S. Government printing office, Washington, DC. 7th Ed.
153. He F.J., Nowson C.A., Lucas M., MacGregor G.A. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: Meta-analysis of cohort studies. J Hum Hypertens 2007, 21(9):717-728.
154. He F., Nowson C., MacGregor G. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006, 367(9507):320-326.
155. Riboli E., Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003, 78(3 Suppl):559S-569S.
156. Buchholz A.C., Schoeller D.A. Is a calorie a calorie?. Am J Clin Nutr 2004, 79(5):899S-906S.
157. Ebbeling C., Swain J., Feldman H., Wong W., Hachey D., Garcia Lago E., et al. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA (Chicago, Ill.) 2012, 307(24):2627-2634.
158. Shao Q., Chin K. Survey of American food trends and the growing obesity epidemic. Nutr Res Pract 2011, 5(3):253-259.
159. Bray G.A., Lovejoy J.C., Smith S.R., DeLany J.P., Lefevre M., Hwang D., et al. The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J Nutr 2002, 132(9):2488-2491.
160. Willett W.C. Dietary fat and obesity: An unconvincing relation. Am J Clin Nutr 1998, 68(6):1149-1150.
161. Hession M., Rolland C., Kulkarni U., Wise A., Broom J. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev 2009, 10(1):36-50.
162. Hamer M., Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97(7):2482-2488.
163. Blher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010, 21(1):38-43.
164. Lee C.D., Blair S.N., Jackson A.S. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 1999, 69(3):373-380.
165. Moussavi N., Gavino V., Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity?. Obesity (Silver Spring) 2008, 16(1):7-15.
166. Schwenk R.W., Holloway G.P., Luiken J.J.F.P., Bonen A., Glatz J.F.C. Fatty acid transport across the cell membrane: Regulation by fatty acid transporters. Prostaglandins Leukot Essent Fat Acids 2010, 82(4-6):149-154.
167. Brookheart R.T., Michel C.I., Schaffer J.E. As a matter of fat. Cell Metab 2009, 10(1):9-12.
168. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1. J Biol Chem 2004, 279(17):16971-16979.
169. Huang S., Rutkowsky J., Snodgrass R., Ono Moore K., Schneider D., Newman J., et al. Saturated fatty acids activate TLR-mediated pro-inflammatory signaling pathways. J Lipid Res 2012.
170. Kuipers R.S., de Graaf D.J., Luxwolda M.F., Muskiet M.H., Dijck-Brouwer D.A., Muskiet F.A. Saturated fat, carbohydrates and cardiovascular disease. Neth J Med 2011, 69(9):372-378.
171. Ramsden C.E., Hibbeln J.R., Majchrzak S.F., Davis J.M. N-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: A meta-analysis of randomised controlled trials. Br J Nutr 2010, 104(11):1586-1600.
172. Ji R., Xu Z., Strichartz G., Serhan C.N. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011, 34(11):599-609.
173. Yehuda S., Rabinovitz S., Mostofsky D.I. Effects of essential fatty acids preparation, (SR-3) on brain biochemistry and on behavioral and cognitive functions. Handbook of essential fatty acids biology: biochemistry, physiology and behavioral neurobiology 1997, 427-452. Humana Press, New York. S. Yehuda, S. Rabinovitz, D.I. Mostofsky (Eds.).
174. Kruizinga A.G., Westenbrink S., van Bosch L.M.C., Jansen M.C.J.F. TNO kwaliteit van leven. De inneming van omega-3 en -6 vetzuren, van vitamines A en E, bij jong volwassenen. Aanvullende berekeningen op basis van voedselconsumptiepeiling 2003 2007, [Report No.: V7451].
175. Gezondheidsraad 2006. Richtlijnen goede voeding 2006. Achtergronddocument. Gezonheidsraad. 2006(A06/08).
176. Kuipers R.S., Luxwolda M.F., Dijck-Brouwer D.A., Eaton S.B., Crawford M.A., Cordain L., et al. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br J Nutr 2010, 104(11):1666-1687.
177. Feskens E.J., Kromhout D. Epidemiologic studies on eskimos and fish intake. Ann N Y Acad Sci 1993, 683:9-15.
178. Bang H.O., Dyerberg J., Hjoorne N. The composition of food consumed by greenland eskimos. Acta Med Scand 1976, 200(1-2):69-73.
179. Dyerberg J., Bang H.O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland eskimos. Am J Clin Nutr 1975, 28(9):958-966.
180. Dyerberg J., Bang H.O., Stoffersen E., Moncada S., Vane J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 1978, 2(8081):117-119.
181. Sinclair A.J., Johnson L., O'Dea K., Holman R.T. Diets rich in lean beef increase arachidonic acid and long-chain omega 3 polyunsaturated fatty acid levels in plasma phospholipids. Lipids 1994, 29(5):337-343.
182. Naughton J.M., O'Dea K., Sinclair A.J. Animal foods in traditional Australian aboriginal diets: Polyunsaturated and low in fat. Lipids 1986, 21(11):684-690.
183. Nelson G.J., Schmidt P.C., Bartolini G., Kelley D.S., Phinney S.D., Kyle D., et al. The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans. Lipids 1997, 32(4):427-433.
184. Kuipers R.S., Fokkema M.R., Smit E.N., van der Meulen J., Boersma E.R., Muskiet F.A. High contents of both docosahexaenoic and arachidonic acids in milk of women consuming fish from Lake Kitangiri (Tanzania): Targets for infant formulae close to our ancient diet?. Prostaglandins Leukot Essent Fat Acids 2005, 72(4):279-288.
185. O'Dea K., Sinclair A.J. Increased proportion of arachidonic acid in plasma lipids after 2 weeks on a diet of tropical seafood. Am J Clin Nutr 1982, 36(5):868-872.
186. Das U.N. Essential fatty acids: Biochemistry, physiology and pathology. Biotechnol J 2006, 1(4):420-439.
187. Muskiet F.A.J., Fokkema M.R., Schaafsma A., Boersma E.R., Crawford M.A. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. J Nutr 2004, 134(1):183-186.
188. Yehuda S., Rabinovitz S.L., Carasso R.I., Mostofsky D. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002, 23(5):843-853.
189. Freeman L.M. Beneficial effects of omega-3 fatty acids in cardiovascular disease. J Small Anim Pract 2010, 51(9):462-470.
190. Gerber M. Omega-3 fatty acids and cancers: A systematic update review of epidemiological studies. Br J Nutr 2012, 107(Suppl 2):S228-S239.
191. Muskiet F.A.J. Pathophysiology and evolutionary aspects of dietary fats and long-chain polyunsaturated faty acids across the life cycle 2010, 19. Frontiers of Neuroscience, Boca Raton (FL). J.P. Montmayeur, J. le Coutre (Eds.).
192. Freeman M.P., Davis M., Sinha P., Wisner K.L., Hibbeln J.R., Gelenberg A.J. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 2008, 110(1-2):142-148.
193. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., et al. Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006, 67(12):1954-1967.
194. Campoy C., Escolano-Margarit M.V., Anjos T., Szajewska H., Uauy R. Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. Br J Nutr 2012, 107(Suppl 2):S85-S106.
195. Karr J.E., Alexander J.E., Winningham R.G. Omega-3 polyunsaturated fatty acids and cognition throughout the lifespan: A review. Nutr Neurosci 2011, 14(5):216-225.
196. Koletzko B., Lien E., Agostoni C., Bohles H., Campoy C., Cetin I., et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: Review of current knowledge and consensus recommendations. J Perinat Med 2008, 36(1):5-14.
197. Sublette M.E., Ellis S., Geant A., Mann J.J. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011, 72(12):1577-1584.
198. Astorg P., Couthouis A., Bertrais S., Arnault N., Meneton P., Guesnet P., et al. Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women. Prostaglandins Leukot Essent Fat Acids 2008, 78(3):171-182.
199. Cunnane S.C., Plourde M., Pifferi F., Begin M., Feart C., Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009, 48(5):239-256.
200. Feart C., Torres M.J., Samieri C., Jutand M.A., Peuchant E., Simopoulos A.P., et al. Adherence to a Mediterranean diet and plasma fatty acids: Data from the Bordeaux sample of the three-city study. Br J Nutr 2011, 106(1):149-158.
201. Barberger-Gateau P., Letenneur L., Deschamps V., Peres K., Dartigues J.F., Renaud S. Fish, meat, and risk of dementia: Cohort study. BMJ 2002, 325(7370):932-933.
202. Kiecolt-Glaser J.K. Stress, food, and inflammation: psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med 2010, 72(4):365-369.
203. Im D.S. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res 2012, 51(3):232-237.
204. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142(5):687-698.
205. Poudyal H., Panchal S.K., Diwan V., Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011, 50(4):372-387.
206. Calder P. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?. Br J Clin Pharmacol 2012.
207. Dubuquoy L., Rousseaux C., Thuru X., Peyrin Biroulet L., Romano O., Chavatte P., et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 2006, 55(9):1341-1349.
208. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 2009, 91(6):791-795.
209. Rietveld A., Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochimica et Biophysica Acta (BBA). Reviews on. Biomembranes 1998, 1376(3):467-479.
210. Sanders T.A. Polyunsaturated fatty acids in the food chain in Europe 1. Am J Clin Nutr 2000, 71(1):176S-178S.
211. Simopoulos A.P. Importance of the omega-6/Omega-3 balance in health and disease: Evolutionary aspects of diet. World Rev Nutr Diet 2011, 102:10-21.
212. Harris W.S. The omega-3 index: From biomarker to risk marker to risk factor. Curr Atheroscler Rep 2009, 11(6):411-417.
213. Luxwolda M.F., Kuipers R.S., Smit E.N., Velzing-Aarts F.V., Dijck-Brouwer D.A., Muskiet F.A.J. The relation between the omega-3 index and arachidonic acid is bell shaped: Synergistic at low EPA+DHA status and antagonistic at high EPA+DHA status. Prostaglandins Leukot Essent Fat Acids 2011, 85(3-4):171-178.
214. Liou Y.A., King D.J., Zibrik D., Innis S.M. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 2007, 137(4):945-952.
215. Nakamura M.T., Nara T.Y. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004, 24:345-376.
216. Gibson R., Muhlhausler B., Makrides M. Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life. Matern Child Nutr 2011, 7(Suppl 2):17-26.
217. Burdge G.C., Calder P.C. Dietary alpha-linolenic acid and health-related outcomes: A metabolic perspective. Nutr Res Rev 2006, 19(1):26-52.
218. Lopez-García E., Schulze M.B., Fung T.T., Meigs J.B., Rifai N., Manson J.E., et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004, 80(4):1029-1035.
219. Lopez-García E., Schulze M.B., Manson J.E., Meigs J.B., Albert C.M., Rifai N., et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134(7):1806-1811.
220. Mayer K., Schaefer M.B., Seeger W. Fish oil in the critically ill: From experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006, 9(2):140-148.
221. Cunnane S.C., Guesnet P. Linoleic acid recommendations. A house of cards. Prostaglandins Leukot Essent Fat Acids 2011.
222. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 2012/01;352(16):1685-95.
223. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
224. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci 1974, 71(9):3400-3404.
225. Borgeat P., Hamberg M., Samuelsson B. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. monohydroxy acids from novel lipoxygenases. J Biol Chem 1976, 251(24):7816-7820.
226. Soberman R.J., Harper T.W., Betteridge D., Lewis R.A., Austen K.F. Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid omega-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. J Biol Chem 1985, 260(7):4508-4515.
227. Bannenberg G.L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K.H., et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005, 174(7):4345-4355.
228. Chiang N., Arita M., Serhan C.N. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fat Acids 2005, 73(3-4):163-177.
229. Serhan C.N., Yang R., Martinod K., Kasuga K., Pillai P.S., Porter T.F., et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009, 206(1):15-23.
230. Spite M., Serhan C.N. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010, 107(10):1170-1184.
231. Merched A.J., Serhan C.N., Chan L. Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis. J Nutrigenet Nutrigenomics 2011, 4(1):12-24.
232. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010, 10(1):36-46.
233. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145(3):341-355.
234. Merched A.J., Ko K., Gotlinger K.H., Serhan C.N., Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008, 22(10):3595-3606.
235. Lee J.H., O'Keefe J.H., Lavie C.J., Marchioli R., Harris W.S. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 2008, 83(3):324-332.
236. Das U.N. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008, 7:37.
237. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., et al. Differential modulation of toll-like receptors by fatty acids: Preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44(3):479-486.
238. Reilly K.B., Srinivasan S., Hatley M.E., Patricia M.K., Lannigan J., Bolick D.T., et al. 12/15-lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem 2004, 279(10):9440-9450.
239. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36(3):233-239.
240. Weaver K., Ivester P., Seeds M., Case L.D., Arm J., Chilton F. Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem 2009, 284(23):15400-15407.
241. Tavazzi L., Maggioni A., Marchioli R., Barlera S., Franzosi M., Latini R., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9645):1223-1230.
242. Itakura H., Yokoyama M., Matsuzaki M., Saito Y., Origasa H., Ishikawa Y., et al. Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb 2011, 18(2):99-107.
243. González-Périz A., Clària J. Resolution of adipose tissue inflammation. Scientific World Journal 2010, 10:832-856.
244. Benzie I.F.F., Wachtel-Galor S. Increasing the antioxidant content of food: a personal view on whether this is possible or desirable. Int J Food Sci Nutr 2012, 63:62-70.
245. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247.
246. Benzie I.F., Wachtel-Galor S. Vegetarian diets and public health: biomarker and redox connections. Antioxid Redox Signal 2010, 13(10):1575-1591.
247. Ames B.N., Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk?. Nat Rev Cancer 2002, 2(9):694-704.
248. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993, 342(8878):1007-1011.
249. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992, 18(1):1-29.
250. Liu R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 2003, 78(3):517S-520S.
251. Engelhart M., Geerlings M., Ruitenberg A., van Swieten J., Hofman A., Witteman J.C.M., et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA (Chicago, Ill.) 2002, 24:3223-3229.
252. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 1999, Clarendon Press, Oxford.
253. Halliwell B. Free radicals and antioxidants: a personal view. Nutr Rev 1994, 52(8):253-265.
254. Cloud P.E. Atmospheric and hydrospheric evolution on the primitive Earth. Both secular accretion and biological and geochemical processes have affected Earth's volatile envelope. Science 1968, 160(3829):729-736.
255. Raymond J., Segrè D. The effect of oxygen on biochemical networks and the evolution of complex life. Science 2006, 311(5768):1764-1767.
256. Laland K.N., Odling-Smee J., Feldman M.W. Niche construction, biological evolution, and cultural change. Behav Brain Sci 2000, 23(01):131.
257. Walker J.C. Atmospheric constraints on the evolution of metabolism. Orig Life Evol Biosph 1980, 10(2):93-104.
258. Fridovich I. Superoxide and evolution. Horiz Biochem Biophys 1974, 1:1-37.
259. Cadenas E. Basic mechanisms of antioxidant activity. Biofactors 1997, 6(4):391-397.
260. Benzie I.F. Evolution of antioxidant defence mechanisms. Eur J Nutr 2000, 39(2):53-61.
261. Evans P., Halliwell B. Micronutrients: Oxidant/antioxidant status. Br J Nutr 2001, 85(Suppl 2):S67-S74.
262. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997, 82(2):291-295.
263. Klarod K., Hongsprabhas P., Khampitak T., Wirasorn K., Kiertiburanakul S., Tangrassameeprasert R., et al. Serum antioxidant levels and nutritional status in early and advanced stage lung cancer patients. Nutrition 2011, 27(11-12):1156-1160.
264. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A 2006, 103(47):17589-17594.
265. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009, 101(Suppl 1):S1-S45.
266. Nakagawa K., Kiko T., Miyazawa T. Carpentero Burdeos G, Kimura F, Satoh A, et al. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br J Nutr 2011, 1-9.
267. Martin H.D., Ruck C., Schmidt M., Sell S., Beutner S., Mayer B., et al. Chemistry of carotenoid oxidation and free radical reactions. Pure Appl Chem 1999, 71(12):2253-2262.
268. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012, 70(5):257-265.
269. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84.
270. Avignon A., Hokayem M., Bisbal C., Lambert K. Dietary antioxidants: Do they have a role to play in the ongoing fight against abnormal glucose metabolism?. Nutrition 2012, 28(7-8):715-721.
271. Chuang C., Martínez K., Xie G., Kennedy A., Bumrungpert A., Overman A., et al. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr 2010, 92(6):1511-1521.
272. Linnane A.W., Ziegler D.M. Studies on the mechanism of oxidative phosphorylation V. the phosphorylating properties of the electron transport particle. Biochim Biophys Acta 1958, 29(3):630-638.
273. Nemoto S., Takeda K., Yu Z.X., Ferrans V.J., Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 2000, 20(19):7311-7318.
274. Sidoti-de Fraisse C., Rincheval V., Risler Y., Mignotte B., Vayssire J.L. TNF-alpha activates at least two apoptotic signaling cascades. Oncogene 1998, 17(13):1639-1651.
275. Babior B.M. The respiratory burst of phagocytes. J Clin Invest 1984, 73(3):599-601.
276. Jones D. Redefining oxidative stress. Antioxid Redox Signal 2006, 8(9-10):1865-1879.
277. Calabrese E., Baldwin L. Hormesis: The dose-response revolution. Annu Rev Pharmacol Toxicol 2003, 43:175-197.
278. Meyer M., Pahl H.L., Baeuerle P.A. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact 1994, 91(2-3):91-100.
279. Ji L.L. Exercise and oxidative stress: role of the cellular antioxidant systems. Exerc Sport Sci Rev 1995, 23:135-166.
280. Hollander J., Fiebig R., Gore M., Ookawara T., Ohno H., Ji L.L. Superoxide dismutase gene expression is activated by a single bout of exercise in rat skeletal muscle. Pflugers Arch 2001, 442(3):426-434.
281. Gomez Cabrera M., Domenech E., Romagnoli M., Arduini A., Borras C., Pallardo F., et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 2008, 87(1):142-149.
282. Via J., Gómez Cabrera M., Borras C. Fostering antioxidant defences: Up-regulation of antioxidant genes or antioxidant supplementation?. Br J Nutr 2007, 98(Suppl 1):S36-S40.
283. Finley J., Kong A., Hintze K., Jeffery E., Ji L., Lei X. Antioxidants in foods: state of the science important to the food industry. J Agric Food Chem 2011, 59(13):6837-6846.
284. Barros M.P., Pinto E., Colepicolo P., Pedersén M. Astaxanthin and peridinin inhibit oxidative damage in Fe2+-loaded liposomes: Scavenging oxyradicals or changing membrane permeability?. Biochem Biophys Res Commun 2001, 288(1):225-232.
285. Halliwell B., Wasil M., Grootveld M. Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Lett 1987, 213(1):15-17.
286. Veeramachaneni S., Wang X. Carotenoids and lung cancer prevention. Front Biosci (Schol Ed) 2009, 1:258-274.
287. Druesne Pecollo N., Latino Martel P., Norat T., Barrandon E., Bertrais S., Galan P., et al. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 2010, 127(1):172-184.
288. Peternelj T., Coombes J. Antioxidant supplementation during exercise training: beneficial or detrimental?. Sports Med 2011, 41(12):1043-1069.
289. Bjelakovic G., Nikolova D., Gluud L., Simonetti R., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA (Chicago, Ill.) 2007, 297(8):842-857.
290. Biesalski H., Grune T., Tinz J., Zllner I., Blumberg J. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients 2010, 2(9):929-949.
291. McNulty H., Jacob R.F., Mason R.P. Biologic activity of carotenoids related to distinct membrane physicochemical interactions. Am J Cardiol 2008, 101(10, Suppl 1):S20-S29.
292. Spiller G.A., Dewell A. Safety of an astaxanthin-rich haematococcus pluvialis algal extract: a randomized clinical trial. J Med Food 2003, 6:51-56.
293. Park J.S., Chyun J.H., Kim Y.K., Line L., Chew B. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab 2010, 7:18.
294. Lavrovsky Y., Chatterjee B., Clark R.A., Roy A.K. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 2000, 35(5):521-532.
295. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 2003, 36(1):95-109.
296. Han K.C., Wong W.C., Benzie I.F.F. Genoprotective effects of green tea (Camellia sinensis) in human subjects: Results of a controlled supplementation trial. Br J Nutr 2011, 105(2):171-179.
297. Arendt B., Ellinger S., Kekic K., Geus L., Fimmers R., Spengler U., et al. Single and repeated moderate consumption of native or dealcoholized red wine show different effects on antioxidant parameters in blood and DNA strand breaks in peripheral leukocytes in healthy volunteers: a randomized controlled trial (ISRCTN68505294). Nutr J 2005, 4:33.
298. Brevik A., Gaivo I., Medin T., Jrgenesen A., Piasek A., Elilasson J., et al. Supplementation of a western diet with golden kiwifruits (Actinidia chinensis var'.hort 16A':) effects on biomarkers of oxidation damage and antioxidant protection. Nutr J 2011, 10:54.
299. Gill C.I.R., Haldar S., Boyd L., Bennett R., Whiteford J., Butler M., et al. Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults. Am J Clin Nutr 2007, 85(2):504-510.
300. Cordain L. Cereal grains: Humanity's double-edged sword. World Rev Nutr Diet 1999, 84:19-73.
301. Bartosz G. Oxidative stress in plants. Acta Physiol Plant 1997, 19:47-64.
302. Hartmann T. From waste products to ecochemicals: fifty years research of plant secondary metabolism. Phytochemistry 2007, 68(22-24):2831-2846.
303. Annual plant reviews volume 39. Functions and biotechnology of plants' secondary metabolites. Second edition 2010, Blackwell Publishing Ltd, Oxford, United Kingdom. 2nd ed. M. Wink (Ed.).
304. Strain J.J. Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 1991, 50(03):591.
305. Holst B., Williamson G. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol 2008, 19(2):73-82.
306. Norman J.T. Antioxidants and disease: more questions than answers. Nutr Res 2000, 20(3):449-459.
307. Sackett D.L., Strauss S.E., Scott Richardson W., Rosenberg W., Hayness R.B. Evidence based medicine. How to practice and teach EBM 2000, Churchill Livingstone, Edinburgh.
308. Blumberg J., Heaney R.P., Huncharek M., Scholl T., Stampfer M., Vieth R., et al. Evidence-based criteria in the nutritional context. Nutr Rev 2010, 68(8):478-484.
309. Mitchell H.L., Aggett P.J., Richardson D.P., Stowell J.D. Food & health forum meeting: evidence-based nutrition. Br J Nutr 2011, 105(2):322-328.
310. Wielders J.P.M., Muskiet F.A.J., van d.W. Shedding new light on vitamin D-Reassessment of an essential prohormone. Ned Tijdschr Geneeskd 2010, 154.
311. Muskiet F.A.J., van d.V., Schuitemaker G.E., Wielders J.P.M. Response to: Towards an adequate intake of vitamin D. an advisory report of the Health Council of The Netherlands. Eur J Clin Nutr 2010, 64(6):655.
312. Weggemans R.M., Schaafsma G., Kromhout D. Towards an adequate intake of vitamin D. An advisory report of The Health Council of The Netherlands. Eur J Clin Nutr 2009, 63(12):1455-1457.
313. Rose G., Hamilton P.J., Colwell L., Shipley M.J. A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 1982, 36(2):102-108.
314. Rose G., Hamilton P.J. A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Community Health 1978, 32(4):275-281.
315. Makrides M., Gibson R.A., Udell T., Ried K. Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am J Clin Nutr 2005, 81(5):1094-1101.
316. McCann J.C., Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005, 82(2):281-295.
317. Simmer K., Schulzke S.M., Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008, (1).
318. Simmer K., Patole S.K., Rao S.C. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008, 1:CD000376.
319. Bischoff Ferrari H.A., Shao A., Dawson Hughes B., Hathcock J., Giovannucci E., Willett W.C. Benefit-risk assessment of vitamin D supplementation. Osteoporos. int 2010, 21(7):1121-1132.
320. Cordain L., Miller J.B., Eaton S.B., Mann N., Holt S.H., Speth J.D. Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets. Am J Clin Nutr 2000, 71(3):682-692.
321. Eaton S.B., Eaton S.B., Konner M.J. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr 1997, 51(4):207-216.
322. Eaton S.B., Eaton SB S.B. Paleolithic vs. modern diets. Selected pathophysiological implications. Eur J Nutr 2000, 39(2):67-70.
323. Klonoff D.C. The beneficial effects of a Paleolithic diet on type 2 diabetes and other risk factors for cardiovascular disease. J Diabetes Sci Technol 2009, 3(6):1229-1232.
324. Frassetto L.A., Schloetter M., Mietus-Synder M., Morris R.C., Sebastian A. Metabolic and physiologic improvements from consuming a Paleolithic, hunter-gatherer type diet. Eur J Clin Nutr 2009, 63(8):947-955.
325. Willett W.C. Balancing life-style and genomics research for disease prevention. Science 2002, 296(5568):695-698.
326. Hemminki K., Lorenzo Bermejo J., Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 2006, 7(12):958-965.
327. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.
328. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985, 14(1):32-38.
329. Rosenberg N.A., Pritchard J.K., Weber J.L., Cann H.M., Kidd K.K., Zhivotovsky L.A., et al. Genetic structure of human populations. Science 2002, 298(5602):2381-2385.
330. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weitgasser R., et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: A global meta-analysis. J Mol Med (Berl). 2007, 85(7):777-782.
331. Bray G.A. Medical consequences of obesity. J Clin Endocrinol Metab 2004, 89(6):2583-2589.
332. Gurven M., Kaplan H. Longevity among hunter-gatherers: a cross-cultural examination. Popul Dev Rev 2007, 33(2):321-365.
333. Hill K., Hurtado A.M., Walker R.S. High adult mortality among Hiwi hunter-gatherers: implications for human evolution. J Hum Evol 2007, 52(4):443-454.
334. Bruggink, J-W., Garssen, J., Lodder, B., Kardal, M. Trends in gezonde levensverwachting. CBS. Bevolkingstrends 1e kwartaal 2009.